Intellia Therapeutics (NTLA) Tax Rate (2015)

Intellia Therapeutics (NTLA) reported Tax Rate of 4.48% for Q4 2015, down 47.56% quarter-over-quarter from 8.54% in Q3 2015.

Intellia Therapeutics (NTLA) Tax Rate (2015) Analysis & Trends

Intellia Therapeutics (NTLA) has 1 years of Tax Rate data on file, last reported at 4.48% in Q4 2015.

Tax Rate for Q4 2015 came in at 4.48%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2016 was 0.93% (changed N/A YoY), and the FY2015 annual result was 7.55%, changed N/A from the prior year.
Tax Rate retreated to 4.48% in Q4 2015 per NTLA's latest filing, from 8.54% in the prior quarter.
Over five years, Tax Rate peaked at 11.16% in Q2 2015 and troughed at 4.48% in Q4 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-57.14
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-6.79
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	5.61
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	17.68
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Intellia Therapeutics	1.86 Bn	1.86 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2015	4.48%
Dec 31, 2015	4.48%
Sep 30, 2015	8.54%
Sep 30, 2015	8.54%
Jun 30, 2015	11.16%
Jun 30, 2015	11.16%
Mar 31, 2015	8.54%
Mar 31, 2015	8.54%